National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2002) Third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 106(25):3143–3421

Goff DC, Jr., Lloyd-Jones DM, Bennett G, Coady S, D'Agostino RB, Sr., Gibbons R et al (2014) 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63(25 Pt B):2935–2959

Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH et al (2014) 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol63(25 Pt B):2889–2934

Sniderman AD, Thanassoulis G, Glavinovic T, Navar AM, Pencina M, Catapano A et al (2019) Apolipoprotein B particles and cardiovascular disease: a narrative review. JAMA Cardiol 4(12):1287–1295

Article  PubMed  PubMed Central  Google Scholar 

Behbodikhah J, Ahmed S, Elyasi A, Kasselman L, De Leon J, Glass A et al (2021) Apolipoprotein B and cardiovascular disease: biomarker and potential therapeutic target. Metabolites 11(10)

Sniderman AD, Williams K, Contois JH, Monroe HM, McQueen MJ, de Graaf J et al (2011) A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk. Circ Cardiovasc Qual Outcomes 4(3):337–345

Article  PubMed  Google Scholar 

Ference BA, Bhatt DL, Catapano AL, Packard CJ, Graham I, Kaptoge S et al (2019) Association of genetic variants related to combined exposure to lower low-density lipoproteins and lower systolic blood pressure with lifetime risk of cardiovascular disease. JAMA 322(14):1381–1391

Article  CAS  PubMed  PubMed Central  Google Scholar 

Richardson TG, Sanderson E, Palmer TM, Ala-Korpela M, Ference BA, Davey Smith G et al (2020) Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: a multivariable Mendelian randomisation analysis. PLoS Med 17(3):e1003062

Article  PubMed  PubMed Central  Google Scholar 

Zuber V, Gill D, Ala-Korpela M, Langenberg C, Butterworth A, Bottolo L et al (2021) High-throughput multivariable Mendelian randomization analysis prioritizes apolipoprotein B as key lipid risk factor for coronary artery disease. Int J Epidemiol 50(3):893–901

Article  PubMed  Google Scholar 

Richardson T, Wang Q, Sanderson E, Mahajan A, McCarthy M, Frayling T et al (2021) Effects of apolipoprotein B on lifespan and risks of major diseases including type 2 diabetes: a Mendelian randomisation analysis using outcomes in first-degree relatives. Lancet Healthy Longev 2(6):e317–e326

Article  PubMed  PubMed Central  Google Scholar 

Glavinovic T, Sniderman AD (2021) Apolipoprotein B: the Rosetta Stone of lipidology. Curr Opin Endocrinol Diabetes Obes 28(2):90–96

Article  CAS  PubMed  Google Scholar 

Visseren F, Mach F, Smulders Y, Carballo D, Koskinas K, Bäck M et al (2021) 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: developed by the task force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC). Eur Heart J 42(34):3227–3337

Article  PubMed  Google Scholar 

Sniderman A, Navar A, Thanassoulis G (2022) Apolipoprotein B vs low-density lipoprotein cholesterol and non–high-density lipoprotein cholesterol as the primary measure of apolipoprotein B lipoprotein-related risk: the debate is over. JAMA Cardiol 7(3):257–258

Article  PubMed  Google Scholar 

Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, National Heart Lung and Blood Institute (2011) Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. J Pediatr 128(Suppl 5):S213–S256

US Preventive Services Task Force (2007) Screening for lipid disorders in children: US Preventive Services Task Force recommendation statement. Pediatrics 120(1):e215–e219

Article  Google Scholar 

Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW, García FA et al (2016) Screening for lipid disorders in children and adolescents: US Preventive Services Task Force recommendation statement. JAMA 316(6):625–633

Article  PubMed  Google Scholar 

Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, National Heart Lung and Blood Institute (2012) Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: full report. U.S. Department of Health and Human Services, National Institutes of Health, and National Heart, Lung and Blood Institute, NIH Publication No. 12–7486, Bethesda, MD, United States

Hagan J, Shaw J, Duncan P (2017) Bright futures: guidelines for health supervision of infants, children, and adolescents. American Academy of Pediatrics, 4th ed. Elk Grove Village, IL, United States

Bright Futures/American Academy of Pediatrics (2021) Recommendations for preventive pediatric health care - periodicity schedule. American Academy of Pediatrics, Elk Grove Village, IL, United States

Moher D, Liberati A, Tetzlaff J, Altman D, Prisma Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097

Ovid Technologies (2020) Embase: excerpta medica database guide. Elsevier B.V. (Corporate Office), Amsterdam, Netherlands. Available from: https://ospguides.ovid.com/OSPguides/embase.htm. Accessed 17 May 2022

Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page M et al (2021) Cochrane handbook for systematic reviews of interventions version 6.2 (updated February 2021). Available from www.training.cochrane.org/handbook. Accessed 17 May 2022

University of Tasmania Library (2020) Systematic reviews for health subject guide. University of Tasmania, Hobart, Australia. Available from: https://utas.libguides.com/SystematicReviews. Accessed 17 May 2022

Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71

Article  PubMed  PubMed Central  Google Scholar 

Twisk J, Kemper H, Mellenbergh D, van Mechelen W (1996) Factors influencing tracking of cholesterol and high-density lipoprotein: the Amsterdam Growth and Health Study. Prev Med 25(3):355–364

Article  CAS  PubMed  Google Scholar 

Flynn J, Kaelber D, Baker-Smith C, Blowey D, Carroll A, Daniels S et al (2017) Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics 140(3)

Committee on Practice Ambulatory Medicine and Bright Futures Periodicity Schedule Workgroup, Simon G, Baker C, Barden G, Brown O, Hackell J et al (2016) 2016 recommendations for preventive pediatric health care. Pediatrics 137(1)

Bramer W, Rethlefsen M, Kleijnen J, Franco O (2017) Optimal database combinations for literature searches in systematic reviews: a prospective exploratory study. Syst Rev 6(1):1–12

Article  Google Scholar 

Wells G, Shea B, O’Connell D, Peterson J, Welch V, Losos M et al (2000) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa, Canada: Ottawa Hospital Research Institute

Deeks J, Higgins J, Altman D, on behalf of the Cochrane Statistical Methods Group (2022) Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page M, et al., editors. Cochrane Handbook for Systematic Reviews of Interventions version 63 (2022). Cochrane. Available from www.training.cochrane.org/handbook. Accessed 17 May 2022

Schünemann H, Brożek J, Guyatt G, Oxman A (2013) GRADE Handbook: Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach. Grading of Recommendations, Assessment, Development and Evaluation (GRADE) Working Group. Available from https://gdt.gradepro.org/app/handbook/handbook.html. Accessed 25 Jan 2023

NHMRC (2019) Guidelines for guidelines: assessing certainty of evidence. Last published 6 September 2019: National Health and Medical Research Council (NHMRC). https://nhmrc.gov.au/guidelinesforguidelines/develop/assessing-certainty-evidence

Bao W, Srinivasan S, Berenson G (1993) Tracking of serum apolipoproteins A-I and B in children and young adults: The Bogalusa Heart Study. J Clin Epidemiol 46(7):609–616

Article  CAS  PubMed  Google Scholar 

del Villar-Rubín S, Escorihuela R, Ortega-Senovilla H, de Oya M, Garcés C (2013) High tracking of apolipoprotein B levels from the prepubertal age to adolescence in Spanish children. Acta Paediatr 102(8):e374–e377

PubMed  Google Scholar 

Kurvinen E, Aasvee K, Zordania R, Jauhiainen M, Sundvall J (2005) Serum lipid and apolipoprotein profiles in newborns and six-year-old children: the Tallinn Young Family Study. Scand J Clin Lab Invest 65(7):541–550

Article  CAS  PubMed  Google Scholar 

Öhlund I, Hernell O, Hörnell A, Lind T (2011) Serum lipid and apolipoprotein levels in 4-year-old children are associated with parental levels and track over time. Eur J Clin Nutr 65(4):463–469

Article  PubMed  Google Scholar 

Peláez Gómez de Salazar M, Sánchez Bayle M, González-Requejo A, Ruiz-Jarabo Quemada C, Asensio Antón J, Otero de Becerrea J (2000) Perfil lipídico en niños de Rivas-Vaciamadrid. Seguimiento de 2 años. An Esp Pediatr 52(5):443–446

Porkka K, Viikari J, Taimela S, Dahl M, Åkerblom H (1994) Tracking and predictiveness of serum lipid and lipoprotein measurements in childhood: a 12-year follow-up. The Cardiovascular Risk in Young Finns Study. Am J Epidemiol 140(12):1096–1110

Sánchez-Bayle M, Gonzalez-Requejo A, Ruiz-Jarabo C, Asensio J, Baeza J, Vila S et al (1996) Serum lipids and apolipoproteins in Spanish children and adolescents: a 5 year follow-up. Acta Paediatr 85(3):292–294

Article  PubMed  Google Scholar 

Sánchez-Bayle M, Sánchez Bernardo A, Asensio Antón J, Ruiz-Jarabo Quemada C, Baeza Mínguez J, Morales San José M (2005) Seguimiento de 5 años del perfil lipídico en los niños. Estudio Rivas-Vaciamadrid. An Esp Pediatr 63(1):34–38

Srinivasan S, Sharma C, Foster T, Berenson G (1982) Longitudinal changes of serum lipid and apoB levels in a newborn-infant cohort. Metabolism 31(2):167–171

Article  CAS  PubMed  Google Scholar 

Maidowski L, Kiess W, Baber R, Dathan-Stumpf A, Ceglarek U, Vogel M (2023) Tracking of serum lipids in healthy children on a year-to-year basis. BMC Cardiovasc Disord 23(1):386

Article  PubMed  PubMed Central  Google Scholar 

Magnussen C, Thomson R, Cleland V, Ukoumunne O, Dwyer T, Venn A (2011) Factors affecting the stability of blood lipid and lipoprotein levels from youth to adulthood: evidence from the Childhood Determinants of Adult Health Study. Arch Pediatr Adolesc Med 165(1):68–76

Article  PubMed  Google Scholar 

Lee J, Kim H, Kang D, Suh I (2017) The 23-year tracking of blood lipids from adolescence to adulthood in Korea: the Kangwha study. Lipids Health Dis 16(1):221

Article  PubMed  PubMed Central  Google Scholar 

Twisk J, Kemper H, Mellenbergh G, Van Mechelen W (1997) A new approach to tracking of subjects at risk for hypercholesteremia over a period of 15 years: the Amsterdam Growth and Health Study. Eur J Epidemiol 13(3):293–300

Article  CAS  PubMed  Google Scholar 

Strong J, McGill H Jr (1962) The natural history of coronary atherosclerosis. Am J Pathol 40(1):37

CAS  PubMed  PubMed Central  Google Scholar 

McGill H Jr, McMahan A, Gidding S (2008) Preventing heart disease in the 21st century: implications of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study. Circulation 117(9):1216–1227

Article  PubMed  Google Scholar 

Nuotio J, Oikonen M, Magnussen C, Viikari J, Hutri-Kähönen N, Jula A et al (2015) Adult dyslipidemia prediction is improved by repeated measurements in childhood and young adulthood. The Cardiovascular Risk in Young Finns Study. Atherosclerosis 239(2):350–357

Bookstein L, Gidding S, Donovan M, Smith F (1990) Day-to-day variability of serum cholesterol, triglyceride, and high-density lipoprotein cholesterol levels. Arch Intern Med 150(8):1653–1657

Article  CAS  PubMed  Google Scholar 

Gillman M, Cupples A, Moore L, Ellison C (1992) Impact of within-person variability on identifying children with hypercholesterolemia: Framingham Children’s Study. J Pediatr 121(3):342–347

Article  CAS  PubMed  Google Scholar 

Jolliffe C, Janssen I (2006) Distribution of lipoproteins by age and gender in adolescents. Circulation 114(10):1056–1062

Article  CAS  PubMed  Google Scholar 

Eissa M, Mihalopoulos N, Holubkov R, Dai S, Labarthe D (2016) Changes in fasting lipids during puberty. J Pediatr 170:199–205

Article  CAS  PubMed  Google Scholar 

Carr S, Hooper A, Sullivan D, Burnett J (2019) Non-HDL-cholesterol and apolipoprotein B compared with LDL-cholesterol in atherosclerotic cardiovascular disease risk assessment. Pathology 51(2):148–154

Article